Similar articles

• Assessment of whether use of a professional medical writer is associated with time to publication of papers reporting phase III oncology clinical trials in two high-impact general medicine journals.

  Hammad M, Carvell-Miller T, Kerr B, Moss V. Hammad M, et al. Curr Med Res Opin. 2025 May;41(5):887-893. doi: 10.1080/03007995.2025.2505697. Epub 2025 May 23. Curr Med Res Opin. 2025. PMID: 40372172
• [The truth disclosure in paediatric oncology].

  Méchinaud F. Méchinaud F. Arch Pediatr. 2007 Jun;14(6):640-3. doi: 10.1016/j.arcped.2007.02.077. Epub 2007 Apr 6. Arch Pediatr. 2007. PMID: 17419028 French. No abstract available.
• Performance of Multimodal Artificial Intelligence Chatbots Evaluated on Clinical Oncology Cases.

  Chen D, Huang RS, Jomy J, Wong P, Yan M, Croke J, Tong D, Hope A, Eng L, Raman S. Chen D, et al. JAMA Netw Open. 2024 Oct 1;7(10):e2437711. doi: 10.1001/jamanetworkopen.2024.37711. JAMA Netw Open. 2024. PMID: 39441598 Free PMC article.
• [Principles of giving full information in oncology].

  Lübbe AS, Nelle I, Stange JH. Lübbe AS, et al. Dtsch Med Wochenschr. 2003 Nov 14;128(46):2441-4. doi: 10.1055/s-2003-43586. Dtsch Med Wochenschr. 2003. PMID: 14614660 Review. German. No abstract available.
• Confronting medical errors in oncology and disclosing them to cancer patients.

  Surbone A, Rowe M, Gallagher TH. Surbone A, et al. J Clin Oncol. 2007 Apr 20;25(12):1463-7. doi: 10.1200/JCO.2006.09.9218. J Clin Oncol. 2007. PMID: 17442988 Review. No abstract available.